In the news

ruth

Raw milk infected with Brucella consumed in 19 states

The CDC says people in 19 states (Alabama, California, Connecticut, Florida, Georgia, Iowa, Maryland, Massachusetts, Michigan, Minnesota, Mississippi, New Jersey, New York, North Carolina, Ohio, Pennsylvania, Rhode Island, South Carolina, and Virginia) have bought or consumed the raw milk from Miller’s Biodiversity Farm, a members-only club in Quarryville, Pennsylvania, that sells dairy products to its members. Authorities connected the farm to a Brucellosis infection in New York in November. The Brucella strain under investigation (RB51), is used in a vaccine in order to protect against more severe forms of Brucella. The bacteria can sometimes make its way into the milk of a vaccinated cow, which can cause those who drink it to develop brucellosis. One cow now removed from the herd tested positive for RB51. The strain is resistant to first-line drugs, the CDC states, and it’s difficult to diagnose because early symptoms resemble the flu. @ https://www.usatoday.com/story/news/2019/02/12/infected-raw-milk-pa-farm-reached-people-19-states-cdc-says/2849261002/

Federal authorities are investigating a Brucella outbreak tied to a Pennsylvania farm producing raw, unpasteurized milk products.

ruth

Update of the FDA Investigating a Multi-state Outbreak of Salmonella Concord Linked to Tahini Produced by Achdut Ltd.

In November 27 of 2018, the CDC and FDA investigated an outbreak of Salmonella concord linked to Tahini imported from Israel and manufactured by Achdut Ltd. Additional products were recalled in December of 2018. More products from the same manufacturer are being recalled now. The FDA is advising consumers not to eat recalled Achva, Achdut, Soom, S&F, and Pepperwood brand tahini and Soom brand Chocolate Sweet Tahini Halva Spread (lot code 071318CH) with expiration dates ranging from April 7, 2020 to May 21, 2020 and Baron’s brand tahini with the expiration date of May 5, 2021. @ https://www.fda.gov/Food/RecallsOutbreaksEmergencies/Outbreaks/ucm626790.htm?utm_campaign=Outbreak%20of%20Salmonella%20Concord%20Linked%20to%20Tahini_02082019&utm_medium=email&utm_source=Eloqua&elqTrackId=B310902428A80F93F181C79521149A35&elq=6972121d80204766a288a37f97dc54a5&elqaid=6688&elqat=1&elqCampaignId=5486

The United States Food and Drug Administration, along with the Centers for Disease Control and Prevention (CDC), and state and local partners, is investigating a multistate outbreak of Salmonella Concord illnesses linked to tahini imported from an Israeli manufacturer, Achdut Ltd., located in Ari’el, Israel.

ruth

BioMérieux Acquires Molecular Testing Firm Invisible Sentinel for $75M

To strengthen its position in food pathogen testing and spoilage organism detection BioMérieux announced today that it has acquired US-based the Invisible Sentinel for approximately $75 million. Invisible Sentinel developed its Veriflow DNA signature capturing technology that combines simple workflows with rapid results, accuracy, and specificity, and does not require sophisticated lab infrastructure. “This acquisition illustrates BioMérieux’s commitment to bring innovative solutions to customers of all sizes to ensure food and beverage quality and contribute to protecting consumer’s health,” Nicolas Cartier, BioMérieux Executive VP of Industrial Microbiology, said in a statement. BioMérieux will adapt Invisible Sentinel’s assays on the molecular food testing Gene-Up system, making them available to customers processing high daily volumes of samples. @ https://www.genomeweb.com/business-news/biom-rieux-acquires-food-beverage-molecular-testing-firm-invisible-sentinel-75m#.XF2qMVxKiM8

BioMérieux will adapt Invisible Sentinel’s Veriflow DNA signature capturing technology on its Gene-Up system for food pathogen detection.

ruth

New steps announced to strengthen FDA process for issuing public warnings on voluntary of recalls

The FDA announced draft guidance for strengthening public warnings and notifications of recalls. They are taking a new step to help ensure appropriate public warnings and notification of recalls when FDA-regulated products are involved. The guidelines describe circumstances when a company should issue a public warning about a voluntary recall, describing the general timeframe for companies to issue such a warning, discusses what information should be included in a public warning, and describes situations where the FDA may take action to issue its own public warning should a company’s warning be deemed insufficient. The FDA claims that in 2018 there were 7,420 recalls with 831 that were classified as the highest risk. That number represents a 5 year low. The figure seems higher because the FDA is communicating more frequently and, in many cases, directly to consumers through the agency’s social media. Scott Gottlieb, M.D., the FDA Commissioner, claims that “Our ability to detect, track and trace potential or known problems with products continues to improve as we implement new technologies across the agency and as companies implement their own technological advances throughout their supply chains. “The FDA is working to improve product traceability by tapping into modern approaches, such as blockchain technology, to further advance our mission of protecting public health. @ https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm630906.htm?utm_campaign=020719_Statement_new%20steps%20to%20strengthen%20process%20for%20issuing%20public%20warnings%20of%20recalls&utm_medium=email&utm_source=Eloqua

Statement from FDA Commissioner Scott Gottlieb, M.D., on new steps to strengthen the agency’s process for issuing public warnings and notifications of recalls